Article Details

Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI319 (Anti-PD-1/CD137 ...

Retrieved on: 2021-07-16 00:00:00

Tags for this article:

Click the tags to see associated articles and topics

Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI319 (Anti-PD-1/CD137 .... View article details on hiswai:

Excerpt

With the innovative mechanism of a bispecific antibody that provides ... of administration, compared to the combination of two monoclonal antibodies. ".

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up